Incidence of COVID-19 Symptom Rebound After Treatment with Remdesivir
Our finding of low rates of COVID-19 symptom rebound after treatment with remdesivir are consistent with the hypothesis that rebound may be less frequent after treatment with remdesivir than with nirmatrelvir-ritonavir.
Authors
- Michael E. Charness (ORCID: https://orcid.org/0000-0002-3301-8966)
- Rebecca Madjarov
- Anna Chen (ORCID: https://orcid.org/0000-0002-5946-6572)
- William J. O’Brien (ORCID: https://orcid.org/0000-0003-3332-926X)
- Katherine Linsenmeyer
- Judith Strymish (ORCID: https://orcid.org/0000-0002-3711-0639)
- Kalpana Gupta (ORCID: https://orcid.org/0000-0002-6766-3576)
Institutions
- Boston University (US)
- Harvard University (US)
- Veterans Health Administration (US)
- VA Boston Healthcare System (US)
Publication Details
- Journal
- Infectious Disease Reports
- Published
- 2025-05-01
- DOI
- https://doi.org/10.3390/idr17030043
- Citations
- 1
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.40